Multiple Myeloma Expertise at University Hospitals Seidman Cancer Center
Cancer specialists at UH Seidman Cancer Center in Cleveland are experts in the diagnosis, treatment and management of multiple myeloma, a cancer that affects plasma cells. Because multiple myeloma affects the immune system, our myeloma specialists determine the best treatment path based on individual needs and how the disease may have led to other issues, including anemia, bone or kidney issues.
From diagnosis through treatment and ongoing myeloma management, including stem cell transplant if necessary, the same clinical team directs and follows each patient’s care. Whether the patient is in the hospital or at home, the myeloma care team helps them through treatment and any issues that may arise in response to clinical therapies.
Personalized Treatment Plans for Myeloma Management
Our myeloma team, led by national experts in cancers of the blood, works collaboratively as part of the hematologic malignancy tumor board to discuss each patient’s treatment plan. Using state-of-the-art technology and the most targeted therapies, the entire team determines each phase of the plan for myeloma management. Myeloma treatment plans may include:
- Targeted agents
- Radiation therapy
- Myeloma-specific clinical trials
- Bone marrow or stem cell transplant
- Care for immune system issues
- Cancer support services
Stem Cell Therapy
Our stem cell transplant program has been offering advanced bone marrow, cord blood or peripheral blood stem cell transplant services for more than 40 years. Our multidisciplinary team of specialists works together to develop individualized treatment plans for each patient, using the latest techniques to provide excellent care and achieve the best possible outcomes.
Myeloma-Specific Clinical Trials
At UH Seidman Cancer Center, our physician-scientists are involved in advancing medicine through research and discovery. With access to myeloma-specific clinical trials, our patients can benefit from innovative therapies, including:
- Monoclonal antibody clinical trial for targeted anti-myeloma therapy
- Minimal residual disease (MRD) detection
Our team is able to target treatment based on the most recent innovations in myeloma care. Using these targeted therapies, our patients have access to treatments that are safe and more tolerable.
Multiple Myeloma Resources Available
Having a better understanding of multiple myeloma causes, prevention, risk factors and symptoms can help patients through their treatment path as directed by the myeloma specialists at University Hospitals. Helpful resources are available to learn more about multiple myeloma, including: